Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Disaggregation of Revenue [Abstract]

Disaggregation of Revenue [Table Text Block]

The following tables disaggregate our revenue from contracts with customers by component and geographic region (in millions). We allocate revenue from contracts with customers to geographic regions based on the location where the sale originated.

	Three Months Ended March 31,
	2023						2022
Businesses	U.S.		Int'l		Total		U.S.		Int'l		Total
Endoscopy	$	351	$	226	$	577	$	312	$	220	$	531
Urology	326		143		469		286		127		413
Neuromodulation	172		62		234		161		49		209
MedSurg	850		430		1,280		758		395		1,153
Interventional Cardiology Therapies	183		408		591		186		358		544
Watchman	265		25		291		203		23		226
Cardiac Rhythm Management	345		203		548		325		195		519
Electrophysiology	85		91		177		50		68		118
Cardiology	879		727		1,606		764		644		1,407
Peripheral Interventions	275		229		503		256		210		465
Cardiovascular	1,154		956		2,110		1,019		853		1,873
Total Net Sales	$	2,003	$	1,386	$	3,389	$	1,778	$	1,248	$	3,026

Refer to Note K- Segment Reporting for information on our reportable segments.

	Three Months Ended March 31,
Geographic Regions	2023		2022
U.S.	$	2,003	$	1,778
Europe, Middle East and Africa	712		624
Asia-Pacific	548		517
Latin America and Canada	126		107
Total Net Sales	$	3,389	$	3,026
Emerging Markets(1)	$	529	$	440

(1)Periodically, we assess our list of Emerging Markets countries, and effective January 1, 2023, modified our list to include all countries except the United States, Western and Central Europe, Japan, Australia, New Zealand and Canada. We have revised prior year amounts to conform to the current year's presentation.